Non-independent Executive Director
Director of CSL Limited since February 2013, and appointed Chief Executive Officer and Managing Director in July 2013.
Skills and experience
Mr Perreault has more than 35 years of experience across both the global biotech and pharmaceutical industries.
He was appointed Chief Executive Officer and Managing Director of CSL Limited in July 2013, and was appointed to the CSL Board of Directors the same year. Since then, CSL has grown to become the third largest biotech company in the world with more than 27,000 employees bringing lifesaving medicines to people in more than 100 countries.
Mr Perreault, who previously served as CSL Behring’s President, joined CSL in 2004 with the acquisition of Aventis Behring. Prior to CSL, he spent more than 15 years in key senior roles at Wyeth-Ayerst Laboratories, now part of Pfizer. Mr Perreault holds a bachelor degree in psychology from the University of Central Florida and completed advanced business management training at the Kellogg and Wharton schools of business.
Other directorships and offices (current and recent):
- Director of the U.S. Pharmaceutical Research and Manufacturers of America (PhRMA) Association (since December 2020)
Board Committee membership:
- Member of the Innovation and Development Committee
- Member of the Securities and Market Disclosure Committee